Jaguar Health (NASDAQ:JAGX) | WebDisclosure

Basculer en Français

10182	Companies
209443	Keywords
139547	Articles
111025	Press releases

Home
Companies
Jaguar Health

PRESS RELEASE

published on 07/08/2024 at 16:30, 1 year 9 months ago

Issuance of New European & Australian Patents Bolster IP Protection for Jaguar Health in the Treatment of Short Bowel Syndrome (SBS) and Congenital Diarrheal Disorders (CDDs)
New patents issued for core rare disease target indications for crofelemer. Jaguar Health announces new patents from European Patent Office and IP Australia for Napo Pharmaceuticals' crofelemer. Expected results in 2024 and 2025

Napo Pharmaceuticals Crofelemer Jaguar Health Patents Rare Disease

Accesswire

Published on 04/09/2026 at 13:30, 1 minute ago

Datametrex Receives $6M Purchase Order for Data Centre from Fortune 500 Conglomerate
Published on 04/09/2026 at 13:00, 31 minutes ago

Red Cloud Securities Initiates Research Coverage on NOA Lithium
Published on 04/09/2026 at 13:00, 31 minutes ago

North Shore Engages Drill Contractor and Continues to Advance Rio Puerco Project
Published on 04/09/2026 at 13:00, 31 minutes ago

BlackBerry Reports Fourth Quarter and Full Fiscal Year 2026 Results
Published on 04/09/2026 at 13:00, 31 minutes ago

NioCorp Reaches Non-Binding Agreement with Traxys North America for Potential Purchase of All of NioCorp's Remaining Planned Products

View all ACCESSWIRE

EQS Group

Published on 04/09/2026 at 12:30, 1 hour 1 minute ago

Immunic to Participate in Scientific and Medical Conferences in April
Published on 04/09/2026 at 12:20, 1 hour 11 minutes ago

AS Invest Capital Ltd Group Launches €50 Million Bond Offering with 8.5% Yield
Published on 04/09/2026 at 12:08, 1 hour 22 minutes ago

Amundi Physical Metals plc: UK Final Terms
Published on 04/09/2026 at 12:08, 1 hour 23 minutes ago

Resolutions of the 2026 annual general meeting of Ørsted A/S
Published on 04/09/2026 at 11:50, 1 hour 41 minutes ago

Golden Frontier and Investor Presentation

Les Echos

Published on 04/09/2026 at 07:00, 6 hours 31 minutes ago

bioMérieux Unveils its BIOFIRE® SPOTFIRE® Molecular Testing Solution for the Pharmaceutical Industry, Redefining Rapid Mycoplasma Testing
Published on 04/09/2026 at 07:00, 6 hours 31 minutes ago

bioMérieux lance sa solution de diagnostic moléculaire BIOFIRE® SPOTFIRE® pour l’industrie pharmaceutique afin de renforcer le dépistage rapide des mycoplasmes
Published on 04/08/2026 at 18:17, 19 hours 13 minutes ago

Mise à disposition du Rapport sur la solvabilité et la situation financière 2025 du Groupe des Assurances du Crédit Mutuel
Published on 04/08/2026 at 18:16, 19 hours 14 minutes ago

Mise à disposition des états financiers 2025 du Groupe des Assurances du Crédit Mutuel
Published on 04/08/2026 at 18:02, 19 hours 29 minutes ago

Publication of the 2025 Universal Registration Document

View all LES ECHOS COMFI WIRE